Besga, A <br/><br/>
Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms.  [electronic resource] 

 -  Neuroscience letters  Feb 2012 
 - 121-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7972 
<br/><br/><label>Standard No.: </label>10.1016/j.neulet.2012.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--metabolism<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Basal Ganglia--pathology<br/>Biomarkers--cerebrospinal fluid<br/>Brain--metabolism<br/>Cholesterol--blood<br/>Female<br/>Humans<br/>Insulin--cerebrospinal fluid<br/>Lanosterol--blood<br/>Magnetic Resonance Imaging<br/>Male<br/>Memory Disorders--metabolism<br/>Middle Aged<br/>Peptide Fragments--cerebrospinal fluid<br/>tau Proteins--cerebrospinal fluid